Literature DB >> 2902873

Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.

I Macquin-Mavier1, F Roudot-Thoraval, C Clerici, C George, A Harf.   

Abstract

1. The effects of single oral doses of 10 mg bisoprolol and 400 mg acebutolol on respiratory function were studied in nine smokers with airway obstruction in a double-blind, placebo-controlled experiment. 2. The effects of the drugs were assessed by measuring specific airway conductance (sGaw) for 3 h after their administration and by studying their interaction with the bronchodilator response to inhaled salbutamol. 3. sGaw did not change for 3 h after bisoprolol or acebutolol administration. The bronchodilator response to inhaled salbutamol was not affected by bisoprolol but significantly reduced by acebutolol (P less than 0.05 vs placebo). 4. Under these conditions, bisoprolol behaves like a selective beta 1-adrenoceptor antagonist but acebutolol exhibits less beta 1-adrenoceptor selectivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902873      PMCID: PMC1386540          DOI: 10.1111/j.1365-2125.1988.tb05278.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis.

Authors:  D J Sinclair
Journal:  Br Med J       Date:  1979-01-20

2.  Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.

Authors:  P Dorow; U Tönnesmann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.

Authors:  T L Whitsett; D C Levin; C V Manion
Journal:  Chest       Date:  1982-12       Impact factor: 9.410

4.  Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.

Authors:  H J Schliep; J Harting
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

5.  Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics.

Authors:  C Skinner; K N Palmer
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

6.  Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.

Authors:  J W Lammers; H T Folgering; C L van Herwaarden
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.

Authors:  A E Tattersfield; D J Cragg; R J Bacon
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

8.  beta-Adrenoceptor blockade and pulmonary function in patients suffering from chronic obstructive lung disease.

Authors:  C L van Herwaarden
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

9.  Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.

Authors:  H R Gribbin; A D Mackay; C J Baldwin; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

10.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

Authors:  A B DUBOIS; S Y BOTELHO; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808

View more
  5 in total

1.  A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.

Authors:  B J Lipworth; N A Irvine; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus.

Authors:  E Naline; B Sarria; O Ertzbischoff; P Ozanne; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 3.  Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Authors:  S Salpeter; T Ormiston; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

4.  Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.

Authors:  Yoshiaki Kubota; Kuniya Asai; Erito Furuse; Shunichi Nakamura; Koji Murai; Yayoi Tetsuou Tsukada; Wataru Shimizu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-05

Review 5.  Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

Authors:  Khaled Albouaini; Mohammed Andron; Albert Alahmar; Mohaned Egred
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.